γH2AX and cancer

被引:0
|
作者
William M. Bonner
Christophe E. Redon
Jennifer S. Dickey
Asako J. Nakamura
Olga A. Sedelnikova
Stéphanie Solier
Yves Pommier
机构
[1] William M. Bonner,
[2] Christophe E. Redon,undefined
[3] Jennifer S. Dickey,undefined
[4] Asako J. Nakamura,undefined
[5] Olga A. Sedelnikova,undefined
[6] Stéphanie Solier and Yves Pommier are at the Laboratory of Molecular Pharmacology,undefined
[7] Center for Cancer Research,undefined
[8] National Cancer Institute,undefined
[9] National Institutes of Health,undefined
[10] Bethesda,undefined
[11] Maryland 20892,undefined
[12] USA.,undefined
来源
Nature Reviews Cancer | 2008年 / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
DNA double strand breaks (DSBs) may lead to cancer but, paradoxically, are also used to kill cancer cells. How might γH2AX — a surrogate marker of DSBs — be used to detect precancerous cells, to stage cancers, to monitor the effectiveness of cancer therapies and to develop novel anticancer drugs?
引用
收藏
页码:957 / 967
页数:10
相关论文
共 50 条
  • [1] γH2AX in cancer cells
    Sedelnikova, Olga A.
    Bonner, William M.
    CELL CYCLE, 2006, 5 (24) : 2909 - 2913
  • [2] OPINION γH2AX and cancer
    Bonner, William M.
    Redon, Christophe E.
    Dickey, Jennifer S.
    Nakamura, Asako J.
    Sedelnikova, Olga A.
    Solier, Stephanie
    Pommier, Yves
    NATURE REVIEWS CANCER, 2008, 8 (12) : 957 - 967
  • [3] H2AX a Promising Biomarker for Lung Cancer: A Review
    Matthaios, D.
    Hountis, P.
    Karakitsos, P.
    Bouros, D.
    Kakolyris, S.
    CANCER INVESTIGATION, 2013, 31 (09) : 582 - 599
  • [4] H2AX and lung cancer: Is it the Ariadne's thread?
    Matthaios, D.
    Bouros, D.
    Kakolyris, S.
    DNA REPAIR, 2013, 12 (02) : 90 - 91
  • [5] H2AX is a Novel Prognostic Marker of Breast Cancer
    Katsuta, E.
    Ouchi, M.
    Ouchi, T.
    Takabe, K.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S55 - S55
  • [6] H2AX is a novel prognostic marker of breast cancer
    Katsuta, Eriko
    Ouchi, Mutsuko
    Ouchi, Toru
    Takabe, Kazuaki
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Can ΥH2AX be Used to Personalise Cancer Treatment?
    Shah, K.
    Cornelissen, B.
    Kiltie, A. E.
    Vallis, K. A.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (10) : 1591 - 1602
  • [8] H2AX IN HYPOXIA AND NEOVASCULARIZATION
    Hammond, E.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S63 - S63
  • [9] γ-H2AX illuminates meiosis
    Neil Hunter
    G Valentin Börner
    Michael Lichten
    Nancy Kleckner
    Nature Genetics, 2001, 27 : 236 - 238
  • [10] Translocations, tumours and H2AX
    Emma Greenwood
    Nature Reviews Cancer, 2003, 3 : 634 - 634